Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
General Thoracic and Cardiovascular Surgery
Erschienen in: General Thoracic and Cardiovascular Surgery 3/2018

06.12.2017 | Current Topics Review Article

Review: surgical treatment of giant coronary aneurysms in pediatric patients with Kawasaki disease

verfasst von: Masami Ochi

Erschienen in: General Thoracic and Cardiovascular Surgery | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

In Kawasaki disease (KD), giant coronary aneurysms in the proximal segments of the coronary arteries have long been among the serious complications associated with acute myocardial infarction. To treat myocardial ischemia in children, Kitamura et al. first performed coronary artery bypass grafting in a pediatric patient using an autologous saphenous vein. In the early 1980s, they began to use the internal thoracic artery (ITA) as a bypass graft to the left anterior descending artery, which later was proven to improve long-term life expectancy with its favorable long-term patency, as well as growth potential. Thus, the excellent characteristics of the ITA have come to be widely known among pediatric cardiac surgeons, and a growing number of coronary bypass surgery procedures using the ITA are now being performed worldwide. Although a longer follow-up with more patients is necessary, downsizing reconstructive procedure may be a treatment of choice for giant aneurysms of non-LAD territories to improve coronary circulation. The efficacy of surgical treatment for giant coronary aneurysms in pediatric patients with Kawasaki disease is now well established. Pediatric coronary artery bypass grafting using the ITA, either single or bilateral, can be safe not only for patients with Kawasaki coronary disease but also for infants with congenital coronary lesions.
Literatur
1.
Kawasaki T, Kosakai F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974;54:271–6.PubMed
2.
Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics. 1978;61:100–7.PubMed
3.
Landing BH, Larson E. Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome). Am J Cardiovasc Pathol. 1987;1:218–29.PubMed
4.
Naoe S, Takahashi K, Masuda H, Tanaka N. Kawasaki disease. With parcicular emphasis on arterial lesions. Acta Pathol Jpn. 1991;41:785–97.PubMed
5.
Amano S, Hazama F, Hamashima Y. Pathology of Kawasaki disease: II. Distribution and incidence of the vascular lesions. Jpn Circ J. 1979;43:741–8.CrossRefPubMed
6.
Ohkubo T, Fukazawa R, Ikegami E, Ogawa S. Reduced shear stress and disturbed flow may lead to coronary aneurysm and thrombus formations. Pediat Int. 2007;49:1–7.CrossRef
7.
Kuramochi Y, Ohkubo T, Takechi N, Fukumi D, Uchikoba Y, Ogawa S. Hemodynamic factors of thrombus formation in coronary aneurysms associated with Kawasaki disease. Pediatr Int. 2000;42:470–5.CrossRefPubMed
8.
Hamaoka K, Onouchi S. Effects of coronary artery aneurysms on intracoronary flow velocity dynamics in Kawasaki disease. Am J Cardiol. 1996;77:873–5.CrossRefPubMed
9.
Subcommittee of cardiovascular sequelae SoST, Kawasaki Disease Research Committee. Guidelines for treatment and management of cardiovascular sequelae in Kawasaki disease. Heart Vessels. 1987; 3:50–4.CrossRef
10.
Kato H, Sugimura T, Akagi T, Sato N, Hashino K, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation. 1996;94(6):1379–85.CrossRefPubMed
11.
JCS Joint Working Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Circ J Jpn Circu Soc, 2014;78:2521–2562.
12.
Nakano H, Ueda K, Saito A, Nojima K. Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease. Am J Cardiol. 1985;56:846–51.CrossRefPubMed
13.
Suzuki A, Kamiya T, Arakaki Y, Kinoshita Y, Kimura K. Fate of coronary arterial aneurysms in Kawasaki disease. Am J Cardiol. 1994;74:822–4.CrossRefPubMed
14.
Kato H, Ichinose E, Kawasaki T. Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases. J Pediatr. 1986;108:923–7.CrossRefPubMed
15.
Suda K, Kudo Y, Higaki T, Nomura Y, Miura M, et al. Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease. Circ J. 2009;73:1319–23.CrossRefPubMed
16.
Sugahara Y, Ishii M, Muta H, Iemura M, Matsuishi T, Kato H. Warfarin therapy for giant aneurysm prevents myocardial infarction in Kawasaki disease. Pediatr Cardiol. 2008;29:398–401.CrossRefPubMed
17.
Onouchi Z, Hamaoka K, Sakata K, Ozawa S, Shiraishi I, et al. Long-term changes in coronary artery aneurysms in patients with Kawasaki disease: comparison of therapeutic regimens. Circ J. 2005;69:265–72CrossRefPubMed
18.
Levy DM, Silverman ED, Massicotte MP, McCrindle BW, Yeung RS. Longterm outcomes in patients with giant aneurysms secondary to Kawasaki disease. J Rheumatol. 2005;32:928–34PubMed
19.
Su D, Wang K, Qin S, Pang Y. Safety and efficacy of warfarin plus aspirin combination for giant coronary aneurysm secondary to Kawasaki disease: a meta-analysis. Cardiology 2014;129:55–64CrossRefPubMed
20.
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, et al. American academy of pediatrics. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110:2747–71CrossRefPubMed
21.
Kitamura S, Kawashima Y, Fujita T, Mori T, Oyama C. Aortocoronary bypass grafting in a child with coronary artery obstruction due to mucocutaneous lymphnode syndrome: report of a case. Circulation. 1976;53:1035–40.CrossRefPubMed
22.
Suma K, Takeuchi Y, Shiroma K, et al. Early and late postoperative studies in coronary arterial lesions resulting from Kawasaki’s disease in children. J Thorac Cardiovasc Surg 1982;84:224–9PubMed
23.
Kitamura S, Kawachi K, Harima R, Sakakibara T, Hirose H, Kasashima Y. Surgery for coronary heart disease due to mucocutaneous lymph node syndrome (Kawasaki disease). Report of 6 patients. Am J Cardiol 1983;51:444–8.CrossRefPubMed
24.
Kitamura S, Kawachi K, Oyama C, Miyagi Y, Morita R, Koh Y, et al. Severe Kawasaki heart disease treated with an internal mammary artery graft in pediatric patients. A first successful report. J Thorac Cardiovasc Surg. 1985;89:860–6.PubMed
25.
Kitamura S, Seki T, Kawachi K, Morita R, Kawata T, Mizuguchi K, et al. Excellent patency and growth potential of internal mammary artery grafts in pediatric coronary artery bypass surgery. New evidence for a “live” conduit. Circulation 1988;78(1):I 129-I 139.
26.
Kitamura S, Kawachi K, Seki T, Morita R, Nishii T, Mizuguchi K, et al. Bilateral internal mammary artery grafts for coronary artery bypass operations in children. J Thorac Cardiovasc Surg 1990;99:708–15.PubMed
27.
Kameda Y, Kitamura S, Taniguchi S, Kawata T, Mizuguchi K, et al. Differences in adaptation to growth of children between internal thoracic artery and saphenous vein coronary bypass grafts. J Cardiovasc Surg (Torino). 2001;42:9–16.
28.
Wakisaka Y, Tsuda E, Yamada O, Yagihara T, Kitamura S. Long-term results of saphenous vein graft for coronary stenosis caused by Kawasaki disease. Cir J. 2009;73:73–7.CrossRef
29.
Kitamura S, Kameda Y, Seki T, Kawachi K, Endo M, Takeuchi Y, et al. Long-term outcome of myocardial revascularization in patients with Kawasaki coronary artery disease. A multicenter cooperative study. J Thorac Cardiovasc Surg 1994;107:663–73.PubMed
30.
Yoshikawa Y, Yagihara T, Kameda Y, Taniguchi S, Tsuda E, Kawahira Y, et al. Result of surgical treatments in patients with coronary-arteial obstructive disease after Kawasaki disease. Eur J Cardiothorac Surg. 2000;17:515–9.CrossRefPubMed
31.
Kitamura S, Tsuda E, Kobayashi J, Yoshikawa Y, Yagihara T, et al. Twenty-five-year outcome of pediatric coronary artery bypass surgery for Kawasaki disease. Circulation. 2009;120:60–8.CrossRefPubMed
32.
Takeuchi Y, Gomi A, Okamura Y, Mori H, Nagashima M. Coronary revascularization in a child with Kawasaki disease: use of right gastroepiploic artery. Ann Thorac Surg. 1990;50:294–6.CrossRefPubMed
33.
Mavroudis C, Backer CL, Duffy CE, Pahl E, Wax DF. Pediatric coronary artery bypass for Kawasaki congenital, post arterial switch, and iatrogenic lesions. Ann Thorac Surg. 1999; 68:506–12.CrossRefPubMed
34.
Coskun KO, Coskun ST, El Arousy M, Aminparsa M, Hornik L, et al. Pediatric patients with Kawasaki disease and a case report of Kitamura operation. ASAIO J. 2006;52:e43–e7.CrossRefPubMed
35.
Newburger JW, Fulton DR. Coronary revascularization in patients with Kawasaki disease. J Pediatr. 2010;157:8–10.CrossRefPubMed
36.
Viola N, Alghamdi AA, Al-Radi OO, Coles JG, Van Arsdell GS, Caldarone CA. Midterm outcomes of myocardial revascularization in children. J Thorac Cardiovasc Surg. 2010;139:333–8.CrossRefPubMed
37.
Legendre A, Chantepie A, Belli E, Vouhe PR, Neville P, Dulac Y, et al. Outcome of coronary artery bypass grafting performed in young children. J Thorac Cardiovasc Surg. 2010;139:349–53.CrossRefPubMed
38.
Vida VL, Torregrossa G, De Franceschi M, Padalino MA, Belli E, Berggren H, et al. European Congenital Heart Surgeons Association (ECHSA). Pediatric coronary artery revascularization: a European multicenter study. Ann Thorac Surg 2013;96:898–903.CrossRefPubMed
39.
Suzuki S, Kamiya T, Ono Y, Takahashi N, Naito Y, Kou Y. Indication of aorto-coronary bypass for coronary arterial obstruction due to Kawasaki disease. Heart Vessels 1985;1:94–100.CrossRefPubMed
40.
Suzuki A, Kamiya T, Ono Y, Kinoshita Y, Kawamura S, Kimura K. Clinical significance of morphologic classification of coronary arterial segmental stenosis due to Kawasaki disease. Am J Cardiol 1993;71:1169–73.CrossRefPubMed
41.
42.
Yamauchi H, Ochi M, Fujii M, Hinokiyama K, Ohmori H, et al. Optimal time of surgical treatment of Kawasaki coronary artery disease. J Nippon Mde Sch. 2004;71:279–86.CrossRef
43.
Tsuda E, Hirata T, Matsuo O, Abe T, Sugiyama H, Yamada O. The 30-year outcome for patients after myocardial infarction due to coronary artery lesions caused by Kawasaki disease. Pediatr Cardiol. 2011;32:176–82.CrossRefPubMed
44.
Tsuda E, Hamaoka K, Suzuki H, Sakazaki H, Murakami Y, Nakagawa M, et al. A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease. Am Heart J. 2014;167:249–58.CrossRefPubMed
45.
Tsuda E, Kitamura S, Kimura K, Kobayashi J, Miyazaki S, Echigo S, et al. Long-term patency of internal thoracic artery grafts for coronary artery stenosis due to Kawasaki disease: comparison of early with recent results in small children. Am Heart J. 2007;153:995–1000.CrossRefPubMed
46.
Tsuda E, Fujita H, Yagihara T, Yamada O, Echigo S, Kitamura S. Competition between native flow and graft flow after coronary artery bypass grafting. Impact on indications for coronary artery bypass grafting for localized stenosis with giant aneurysms due to Kawasaki disease. Pediatr Cardiol. 2008;29:266–70.CrossRefPubMed
47.
Ogawa S, Ohkubo T, Fukazawa R, Kamisago M, Kuramochi Y, UchikobaY, et al. Estimation of myocardial hemodynamics before and after intervention in children with Kawasaki disease. J Am Coll Cardiol. 2004;43:653–61.CrossRefPubMed
48.
Kitamura S. Long-term graft patency and surgical outcomes of coronary artery bypass surgery in children with Kawasaki disease. Saji BT et al, Kawasaki diseaseeditors. Springer, Japan 2017:407–17.CrossRef
49.
Maruyama Y, Ochi M. Long-term outcomes of pediatric coronary artery bypass grafting and down-sizing operation for giant coronary aneurysm. Saji BT et al (eds) Kawasaki disease. Springer, Japan 2017:389–406.CrossRef
Metadaten
Titel
Review: surgical treatment of giant coronary aneurysms in pediatric patients with Kawasaki disease
verfasst von
Masami Ochi
Publikationsdatum
06.12.2017
Verlag
Springer Japan
Erschienen in
General Thoracic and Cardiovascular Surgery / Ausgabe 3/2018
Print ISSN: 1863-6705
Elektronische ISSN: 1863-6713
DOI
https://doi.org/10.1007/s11748-017-0877-7

Weitere Artikel der Ausgabe 3/2018

General Thoracic and Cardiovascular Surgery 3/2018 Zur Ausgabe

Case Report

Late-onset chest wall abscess due to a biodegradable rib pin infection after lung transplantation

Original Article

Lung necrosectomy in pediatric patients with necrotizing pneumonia

Original Article

Development of a simple device enabling percutaneous flow regulation for a small vascular graft for a Blalock–Taussig shunt capable of flow regulation: complete translation of a review article originally published in Pediatric Cardiology and Cardiac Surgery (154–159, 2016: vol. 32)

Current Topics Review Article

Extracorporeal lung support for advanced lung failure: a new era in thoracic surgery and translational science

Correction

Correction to: Valve-sparing aortic root surgery. CON: remodeling

Correction

Correction to: Current status of cardiovascular surgery in Japan, 2013 and 2014: A report based on the Japan Cardiovascular Surgery database 3. Coronary artery bypass surgery

Neu im Fachgebiet Chirurgie

17.04.2024 | Postoperative nausea and vomiting | Nachrichten

Hochrisiko-Eingriffe für postoperative Übelkeit

16.04.2024 | Infektiologie | Nachrichten

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

10.04.2024 | Postoperative Schmerztherapie | Nachrichten

Chronische Schmerzen nach Op. oft mit neuropathischer Komponente

10.04.2024 | Narbenhernie | Nachrichten

Deutlich weniger Narbenhernien mit der Small-Bites-Technik
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom CME-Kurs
CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur CME-Kurs
CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis CME-Kurs
CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.